Overview

A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies

Status:
Terminated

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this clinical research study is to learn about the safety and tolerability of daily BMS-275183 in patients with advanced cancer.

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb